ADUS Addus HomeCare Corp Insider Trading

ADUS CEO Allison Dirk sells 7,352 shares for $782,687.28 in two transactions; stock down 15.3% from 52-week high

ADUS CEO Allison Dirk conducted 2 separate sales totaling 7,352 shares (7.4K shares) for $782,687.28 ($782.7K) on 2026-02-24 and 2026-02-25, representing a -3.9% reduction in her 190,502 share holdings. The transactions occurred at prices ($106.46 blended average) near current market levels ($104.02), while the stock remains down 13.5% over 90 days and 15.3% from its 52-week high of $122.75. Her prior 4 measurable sales at ADUS showed 50% well-timed outcomes at the 90-day mark (2 of 4 prior sells saw subsequent declines), and across all tickers her cross-ticker track record reflects a 71.43% well-timed rate on 15 prior sells. The company fundamentals remain solid with $362.3M quarterly revenue, +23.2% annual growth, and a 17.84 P/E ratio, offering limited context for strategic repositioning.

ADUS CEO Allison Dirk sold 4,535 shares at $114.91 on 2026-02-23 (value: $521,116.85); stock now at $105.20, -14.3% from 52-week high.

Allison Dirk, Chairman and CEO of Addus HomeCare Corp (ADUS), sold 4,535 shares at $114.91, representing a -2.3% reduction in her 195,037-share position. The transaction occurred when the stock was trading closer to its 52-week high of $122.75; the stock has since declined to $105.20, down -14.3% from that high and -4.7% over 30 days, -13.0% over 90 days. Across her cross-ticker trading history, Dirk's prior sells have been well-timed 71.43% of the time on a 90-day basis, though at ADUS specifically her prior four measurable sales showed mixed results (2 of 4 well-timed at 90 days). The company's fundamentals remain solid with $362.3M in latest-quarter revenue, +23.2% annual growth, and a 18.04 P/E, making the stock's recent weakness noteworthy but not necessarily indicative of operational stress.

EVP Anderson Darby sold 20,000 shares at $109.00 for $2,180,000; holdings reduced 31.2% to 44,144 shares

Anderson Darby, EVP and Chief Government Relations Officer, sold 20,000 shares (20.0K shares) at $109.00 on 2025-11-19 for a total value of $2,180,000.00, reducing his holdings from 64,144 shares to 44,144 shares—a 31.2% reduction in his position. The stock currently trades at $110.07, near the sale price, and has declined 9.4% over the last 30 days and 7.0% over 90 days, now trading 19.0% below its 52-week high of $135.92. ADUS fundamentals remain solid with $362.3M in quarterly revenue, $22.8M in net income, 9.1% annual revenue growth, and a P/E of 23.77 at a $2.0B market cap. The transaction represents a substantial reduction in a senior executive's direct equity stake rather than a minor portfolio adjustment, which merits investor attention given the material size relative to his pre-transaction holdings and the executive's governance role.

ADUS CEO Allison Dirk sells 25,000 shares for $2.9M; prior 90d outcomes mixed at this ticker

Allison R Dirk, Chairman and CEO of Addus HomeCare Corp, executed 2 separate sales totaling 25,000 shares for $2,895,749.70 on 2025-09-02, reducing her holdings by 13.1% from 191,461 to 166,461 shares. The blended average sale price of $115.83 compares to the current price of $113.10, and the stock is -16.8% from its 52-week high of $135.92, suggesting the sale occurred near recent peaks. Her cross-ticker track record shows an 80.00% well-timed rate across 12 prior sells, but at ADUS specifically, the track record is mixed: 2 of 3 measurable prior sales achieved negative 90-day returns (well-timed), while one posted +3.7%, indicating inconsistent execution timing at this ticker. The 30-day gain of +5.7% in the 30 days post-announcement supports scrutiny of the sale timing relative to near-term momentum.

CFO Brian Poff sells 7.7K ADUS shares for $904.1K; stock down 16% from 52-week high, but his prior 2 sales at this ticker have been well-timed.

Brian Poff, EVP and CFO of Addus HomeCare, executed 2 separate sales totaling 7,739 shares for $904,087.59 at blended average price $116.82 on 2025-08-25, reducing his holdings by -12.0% to 56,980 shares. The timing is notable: stock is currently at $114.15, down 16.0% from its 52-week high of $135.92, yet both of his prior sales at ADUS (2024-09-12) showed negative 90-day returns (-5.9% and -6.3%), indicating he has been well-timed in selling before subsequent declines at this ticker. The 30-day positive change of +4.3% suggests modest recent recovery, but his historical pattern at ADUS points to selling ahead of weakness. Fundamentals remain solid with annual revenue growth of +9.1% and P/E of 25.31, placing the company in a mid-cap health-services profile, but the insider's consistent pattern of selling near peaks warrants investor attention.

ADUS CEO ALLISON R DIRK sells 25,000 shares across 2 transactions for $2,873,850.80 on 2025-08-20

ALLISON R DIRK, Chairman and CEO of Addus HomeCare Corp, executed two separate sales on 2025-08-20 totaling 25,000 shares (25.0K shares) for $2,873,850.80, reducing her holdings from 191,461 to 166,461 shares (-13.1% of pre-transaction holdings). The sales occurred at a blended average price of $114.95, which is currently trading at $114.18, positioning this transaction at -16.0% from the 52-week high of $135.92. Her prior sales at ADUS show a 4-of-5 pattern of well-timed 90-day outcomes, with only the 2025-02-24 sale failing to post negative subsequent returns; however, her broader cross-ticker track record averaged a 90d well-timed rate of 80.00%, suggesting consistent sell-timing discipline. The company's fundamentals remain solid with $349.4M in latest quarterly revenue, $22.1M net income, and +9.1% annual revenue growth, though the 25.32 P/E ratio sits elevated relative to historical context.

ADUS COO BICKHAM W BRADLEY sold 9,000 shares for $1,038,100.00 in 2 transactions on 2025-08-13.

BICKHAM W BRADLEY, President and COO, executed 2 separate sales totaling 9,000 shares for $1,038,100.00 at a blended average price of $115.34 on 2025-08-13, reducing his holdings from 50,605 to 41,605 shares (-17.8%). This sale occurs while the stock is at $115.11 current price, +6.2% over the prior 30 days and +3.1% over 90 days, and sits 15.3% below its 52-week high of $135.92. Notably, his prior sales at ADUS (on 2024-08-30 and 2024-08-29) both registered negative 90-day returns, with 2 of 2 prior sells well-timed at the 90-day mark according to TRACK RECORD. The company's fundamentals remain solid: $349.4M quarterly revenue, $22.1M net income, +9.1% annual revenue growth, and a P/E of 25.52 with $2.1B market cap. This sale represents a material reduction in insider equity stake by an officer in a relatively recent growth-oriented company, though the sale price aligns closely with current market valuation.

CEO Allison R Dirk sold 8,203 shares of ADUS at $108.18 on 2025-02-24; stock now -28.2% from 52-week high.

Allison R Dirk, CEO and Chairman of Addus HomeCare Corp, sold 8,203 shares at $108.18 for $887,400.54, reducing her holdings by 7.2% to 105,525 shares. The sale price was 11.1% above the current market price of $97.53, and ADUS has declined 25.3% in the past 30 days and 19.6% in the past 90 days. Her prior five trades at ADUS (all sells) showed negative 90-day returns in 3 of 3 measurable instances, with a timing pattern where all prior 90-day outcomes were well-timed declines. The company maintains solid fundamentals: $289.8M in latest quarterly revenue, $20.2M net income, 9.1% annual revenue growth, and a P/E of 20.93 on a $1.8B market cap. The timing of this sale—executed at a price significantly above current levels and consistent with her prior sell pattern at this ticker—warrants investor attention given the sharp recent price deterioration.

CEO Allison Dirk sold 25,000 shares (25.0K shares) at blended average $124.76 on 2025-01-02 for $3,118,876.70.

CEO and Chairman Allison Dirk executed two separate sales totaling 25,000 shares for $3,118,876.70 at prices of $124.59 and $125.17, reducing her holdings from 104,397 to 79,397 shares. This represents a -23.9% reduction in her position. While the scale of the sale is material, her prior sales history at ADUS provides limited guidance: across five prior trades at this ticker, only one has reached a measurable 90-day outcome (the 2024-02-26 sale returned +29.8%), leaving timing assessment inconclusive at the same-ticker level. The stock trades near its 52-week high ($133.58) and the company reports solid fundamentals with 11.3% annual revenue growth and a P/E of 30.69. The transaction occurred during seasonally active trading but without supporting context (10b5-1 plan status, scheduled lock-up expiry, or other event FLAGS), the magnitude of the sale and its proximity to all-time highs warrant investor attention to future guidance and earnings trends.

CEO Allison Dirk sells 12,500 shares (8.1% of holdings) for $1,539,555.91 at ADUS, blended avg $123.16

Allison Dirk, CEO and Chairman of Addus HomeCare Corp, executed four separate sales totaling 12,500 shares for $1,539,555.91 on 2024-11-25 at prices ranging from $122.58 to $125.17 (blended average $123.16). This represents an 8.1% reduction of her pre-transaction holdings (154,397 shares down to 141,897 shares). The sale occurred near the 52-week high of $133.58 (6.9% below peak) and comes as the stock has declined 2.8% over 30 days and 5.8% over 90 days. Dirk's prior trades at ADUS show mixed timing outcomes: two of three prior sales were well-timed at the 90-day mark, though one sale on 2024-02-26 resulted in significant 90-day gains of 29.8%, indicating poorly-timed execution on that occasion. The company's fundamentals remain solid with annual revenue growth of 11.3%, quarterly revenue of $289.8M, net income of $20.2M, and a market cap of $2.3B, though the P/E ratio of 30.64 suggests elevated valuation relative to earnings.